News archive

In order to create a customized form of cartilage tissue, which has always been difficult to date, scientists at Technical University Vienna are pursuing a new approach using a precision 3D printing process.

Using human cells from a 3D printer, a team of researchers from the US, Singapore and China have created tissue that looks and functions like a piece of brain.

3Rs Student Grants 2024: call for submissions

Wednesday, 14 February 2024 11:31

The European Partnership for Alternative Approaches to Animal Testing (EPAA) helps students and young scientists with outstanding work in the field of alternative approaches to attend a high-profile scientific event.

NIH to invest increased in NAMs

Tuesday, 13 February 2024 12:37

Last week, the Director of the National Institutes of Health (NIH), Dr. Monica Bertagnolli, accepted the Advisory Committee's to consider approaches that use new alternative methods in biomedical and behavioral research.

At the end of January, French in vitro neuroscientist Dr. Alexandra Benchoua was honored for her development of an animal-free method that can be used to investigate neurological and psychiatric diseases such as autistic spectrum disorders and to find treatment options.

Scientists from the Institute of Transfusion Medicine and Gene Therapy at Freiburg University Medical Center, led by Prof. Toni Cathomen, have received funding of around €1.17 million as part of the British "Crack it" Challenge. The team is researching an innovative, animal-free approach to the safety assessment of modern cancer therapies.

The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB has developed an in vitro dog skin model that can be used to test medical therapeutics for the treatment of canine skin diseases.

The Austrian Science Fund (FWF) is offering an Austria-wide funding program for research into alternative methods to animal testing using resources from the Austrian Ministry of Science. The aim is to accelerate the establishment of alternative methods based on the 3Rs principle.

The European Chemicals Agency (ECHA) has commissioned a consortium with the participation of BASF SE to scientifically investigate the reliability and relevance of new technologies as alternatives to animal testing, so-called New Approach Methodologies (NAMs), and to promote their use in the future. NAMs include in-vitro models, computer methods and omics techniques (genetic analyses of the entire genome, all expressed proteins of a cell and metabolic functions).

As announced by the 3R Center Tübingen on LinkedIN, the renowned scientist for organ-on-chip research at the Eberhard Karls University of Tübingen and NMI Reutlingen, Prof. Peter Loskill, has been appointed to the Permanent Senate Commission for Animal Experimental Research of the German Research Foundation (DFG).